Abstract |
Protein tyrosine phosphatases are important regulators of insulin signal transduction. Our studies have shown that in insulin resistant and diabetic ob/ob and db/db mice, reducing the levels of protein tyrosine phosphatase 1B (PTP1B) protein by treatment with a PTP1B antisense oligonucleotide resulted in improved insulin sensitivity and normalized plasma glucose levels. The mechanism by which PTP1B inhibition improves insulin sensitivity is not fully understood. We have used microarray analysis to compare gene expression changes in adipose tissue, liver and muscle of PTP1B antisense-treated ob/ob mice. Our results show that treatment with PTP1B antisense resulted in the downregulation of genes involved in lipogenesis in both fat and liver, and a downregulation of genes involved in adipocyte differentiation in fat, suggesting that PTP1B antisense acts through a different mechanism than thiazolidinedione (TZD) treatment. In summary, microarray results suggest that reduction of PTP1B may alleviate hyperglycemia and enhance insulin sensitivity by a different mechanism than TZD treatment.
|
Authors | Jeffrey F Waring, Rita Ciurlionis, Jill E Clampit, Sherry Morgan, Rebecca J Gum, Robert A Jolly, Paul Kroeger, Leigh Frost, James Trevillyan, Bradley A Zinker, Michael Jirousek, Roger G Ulrich, Cristina M Rondinone |
Journal | Molecular and cellular endocrinology
(Mol Cell Endocrinol)
Vol. 203
Issue 1-2
Pg. 155-68
(May 30 2003)
ISSN: 0303-7207 [Print] Ireland |
PMID | 12782412
(Publication Type: Journal Article)
|
Chemical References |
- Blood Glucose
- Lipids
- Oligonucleotides, Antisense
- Protein Tyrosine Phosphatase, Non-Receptor Type 1
- Protein Tyrosine Phosphatases
- Ptpn1 protein, mouse
|
Topics |
- Adipose Tissue
(cytology, metabolism)
- Animals
- Blood Glucose
(drug effects)
- Cell Differentiation
(drug effects)
- Down-Regulation
(drug effects)
- Gene Expression Profiling
- Gene Expression Regulation
(drug effects)
- Insulin Resistance
- Lipids
(biosynthesis)
- Liver
(metabolism)
- Mice
- Mice, Obese
- Muscles
(metabolism)
- Oligonucleotides, Antisense
(pharmacology, therapeutic use)
- Protein Tyrosine Phosphatase, Non-Receptor Type 1
- Protein Tyrosine Phosphatases
(antagonists & inhibitors, physiology)
|